Literature DB >> 10472507

Regulation of intravenously self-administered nicotine in rats.

W J Lynch1, M E Carroll.   

Abstract

Ten male Wistar rats had access to 9 doses of nicotine (0.01-0.10 mg/kg i.v.) during daily 5-hr sessions. Once responding for nicotine stabilized, nicotine infusions were replaced with either cocaine infusions (0.0-2.4 mg/kg) or saline infusions. Saline substitution results indicate that nicotine functioned as a reinforcer. Regulation of nicotine intake was compared with that of cocaine by obtaining the correlation between mean interdose interval and preceding dose size. Results reveal that although this correlation was significant for both nicotine and cocaine self-administration, nicotine self-administration was less precisely regulated than cocaine self-administration. This procedure suggests that there are differences in regulation among self-administered drugs and that it may serve as a useful baseline for studying differences in vulnerability to drug abuse and potential treatment strategies.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10472507     DOI: 10.1037//1064-1297.7.3.198

Source DB:  PubMed          Journal:  Exp Clin Psychopharmacol        ISSN: 1064-1297            Impact factor:   3.157


  15 in total

1.  Galantamine, an acetylcholinesterase inhibitor and positive allosteric modulator of nicotinic acetylcholine receptors, attenuates nicotine taking and seeking in rats.

Authors:  Thomas J Hopkins; Laura E Rupprecht; Matthew R Hayes; Julie A Blendy; Heath D Schmidt
Journal:  Neuropsychopharmacology       Date:  2012-06-06       Impact factor: 7.853

2.  A lack of association between severity of nicotine withdrawal and individual differences in compensatory nicotine self-administration in rats.

Authors:  Andrew C Harris; Paul R Pentel; Danielle Burroughs; Mylissa D Staley; Mark G Lesage
Journal:  Psychopharmacology (Berl)       Date:  2011-04-15       Impact factor: 4.530

3.  A glimpse into the future - Personalized medicine for smoking cessation.

Authors:  Laura Jean Bierut; Eric O Johnson; Nancy L Saccone
Journal:  Neuropharmacology       Date:  2013-09-18       Impact factor: 5.250

Review 4.  Recent advances in understanding nicotinic receptor signaling mechanisms that regulate drug self-administration behavior.

Authors:  Luis M Tuesta; Christie D Fowler; Paul J Kenny
Journal:  Biochem Pharmacol       Date:  2011-06-29       Impact factor: 5.858

5.  Dissociating the primary reinforcing and reinforcement-enhancing effects of nicotine using a rat self-administration paradigm with concurrently available drug and environmental reinforcers.

Authors:  Matthew I Palmatier; F Fay Evans-Martin; Alycia Hoffman; Anthony R Caggiula; Nadia Chaudhri; Eric C Donny; Xiu Liu; Sherri Booth; Maysa Gharib; Laure Craven; Alan F Sved
Journal:  Psychopharmacology (Berl)       Date:  2005-10-25       Impact factor: 4.530

6.  Variability of drug self-administration in rats.

Authors:  Leigh V Panlilio; Jonathan L Katz; Roy W Pickens; Charles W Schindler
Journal:  Psychopharmacology (Berl)       Date:  2003-03-18       Impact factor: 4.530

7.  Temporal horizons of cigarette satiety: determining the window of time over which recent smoking influences motivation to smoke.

Authors:  Benjamin P Kowal; Warren K Bickel; Reid D Landes
Journal:  Behav Pharmacol       Date:  2008-07       Impact factor: 2.293

8.  Sex differences in attenuation of nicotine reinstatement after individual and combined treatments of progesterone and varenicline.

Authors:  Natashia Swalve; John R Smethells; Marilyn E Carroll
Journal:  Behav Brain Res       Date:  2016-04-21       Impact factor: 3.332

9.  Nicotine serves as an effective reinforcer of intravenous drug-taking behavior in human cigarette smokers.

Authors:  Deon M Harvey; Sevil Yasar; Stephen J Heishman; Leigh V Panlilio; Jack E Henningfield; Steven R Goldberg
Journal:  Psychopharmacology (Berl)       Date:  2004-03-02       Impact factor: 4.530

10.  Correlates of individual differences in compensatory nicotine self-administration in rats following a decrease in nicotine unit dose.

Authors:  Andrew C Harris; Paul R Pentel; Mark G LeSage
Journal:  Psychopharmacology (Berl)       Date:  2009-05-28       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.